Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and …

Jan 29, 2025 · Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print. Stryker reported quarterly earnings of $4.01 per share, which …

CouponFollow Extension

$4.01
OFF

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale And …

2 weeks from now

Jan 29, 2025 · Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print. Stryker reported quarterly earnings of $4.01 per share, which …

yahoo.com

$6.44
OFF

Stryker's Strategic Moves Impress Analysts, Spine Implant

2 weeks from now

Jan 29, 2025 · Stryker beats Q4 estimates with $6.44B revenue and $4.01 EPS, announces CFO retirement and spine implant business sale. Analysts raise Stryker price targets, citing strong …

benzinga.com

$4.01
OFF

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale And …

2 weeks from now

Jan 29, 2025 · Wall Street analysts rerated Stryker Corp (NYSE: SYK) Wednesday after the company’s fourth-quarter print.. Stryker reported quarterly earnings of $4.01 per share, which …

sahmcapital.com

$4.01
OFF

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale And …

2 weeks from now

Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print.. Stryker reported quarterly earnings of $4.01 per share, which beat the analyst …

smartmoneytrading.net

FAQs about Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and … Coupon?

Will Stryker's spinal implants business thrive as an independent company?

"We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Stryker Chief Executive and Chair Kevin Lobo. Once the sale closes, VB Spine would become a strategic partner to Stryker with access to Mako Spine and Copilot. ...

When will Stryker's spinal implants business close?

The transaction for the U.S. business is set to close in the first half of 2025. "We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Stryker Chief Executive and Chair Kevin Lobo. ...

How did Stryker perform in Q4?

Stryker reported quarterly earnings of $4.01 per share, which beat the analyst consensus estimate of $3.87. The company reported quarterly sales of $6.44 billion, up by 10.7%, which beat the analyst consensus estimate of $6.36 billion. Also Read: Nasdaq Touts 10% Revenue Growth In Q4, Sets 2025 Expense And Tax Guidance ...

Will VB spine buy Stryker?

Once the sale closes, VB Spine would become a strategic partner to Stryker with access to Mako Spine and Copilot. The agreement includes a binding offer to acquire Stryker's spinal implants business in France. Write to Katherine Hamilton at [email protected] ...

What happened at Stryker?

Simultaneous with the earnings release, Stryker also announced the planned retirement of long-time CFO Glenn Boehnlein and the imminent sale of the lower-growth Spine Implant business. Without offering transaction proceed specifics, Stryker highlighted an anticipated first-half U.S. Spine Implant close with international divestitures to follow. ...

Is Stryker a good company?

“We have long admired Stryker for its comprehensive spine portfolio, incredible talent, and strong culture,” said Marc, John and Anthony Viscogliosi, Co-Founders of Viscogliosi Brothers, LLC. ...